Skip to main content
Paul Rosenberg, MD, Psychiatry, Baltimore, MD

PaulBRosenbergMD

Psychiatry Baltimore, MD

Geriatric Psychiatry

Associate Professor of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine; Associate Director, Memory and Alzheimer''s Treatment Center Division of Geriatric Psychiatry and Neuropsychiatry

Dr. Rosenberg is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Rosenberg's full profile

Already have an account?

  • Office

    5300 Alpha Commons Drive
    Baltimore, MD 21224
    Phone+1 410-550-6337
    Fax+1 410-550-5992

Summary

  • Dr. Paul Rosenberg is a psychiatrist in Baltimore, MD and is affiliated with Johns Hopkins Bayview Medical Center. He received his medical degree from University of Maryland School of Medicine and has been in practice 32 years. He specializes in geriatric psychiatry and is experienced in depression, delirium, and dementa. He has > 130 peer-reviewed publications. He is currently recruiting for trials of escitalopram and THC for agitation in Alzheimer's, psilocybin for depression in mild cognitive impairment, and trazodone for sleep and cognition in mild cognitive impairment.

Education & Training

  • Massachusetts General Hospital/McLean Hospital
    Massachusetts General Hospital/McLean HospitalResidency, Psychiatry, 1990 - 1991
  • Tufts Medical Center
    Tufts Medical CenterResidency, Psychiatry, 1988 - 1990
  • Boston University Medical Center
    Boston University Medical CenterInternship, Internal Medicine, 1985 - 1986
  • University of Maryland School of Medicine
    University of Maryland School of MedicineClass of 1985
  • Harvard University
    Harvard UniversityBA, Magna Cum Laude, 1979

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 1991 - 2025
  • MA State Medical License
    MA State Medical License 1986 - 2005
  • American Board of Psychiatry and Neurology Psychiatry

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
  • Paul Beeson Scholar American Foundation for Aging Research, AFAR, 2008

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Effect of Depth of Sedation in Older Patients Undergoing Hip Fracture Repair on Postoperative DeliriumThe STRIDE Randomized Clinical Trial  
    Frederick E Sieber, Allan Gottschalk, Karin J Neufeld, Simon C Mears, Erik A Hasenboehler, Esther S Oh, Mahmood Jaberi, George E Bigelow, Paul B Rosenberg, JAMA
  • Neuropsychiatric Symptoms in Alzheimer's Disease: What Might Be Associated Brain Circuits?  
    Rosenberg PB, Nowrangi MA, Lyketsos CG, Molecular Aspects of Medicine, 1/1/2015
  • Effect of Medications on Physical Function and Cognition in Nursing Home Residents with Dementia  
    Dutcher SK, Rattinger GB, Langenberg P, Chhabra PT, Liu X, Rosenberg PB, Leoutsakos JM, Simoni-Wastila L, Walker LD, Franey CS, Zuckerman IH, J Am Geriatr Soc, 1/13/2014
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Lectures

  • Primary and Secondary Prevention of Alzheimer's Disease 
    Baltimore, MD - 1/27/2014
  • Development of treatments for depression in Alzheimer's Disease 
    Baltimore, MD - 1/8/2014
  • Clinical Trial Challenges in the Study of Age-related Cognitive Disorders 
    1/19/2013
  • Join now to see all

Other

  • Emerging Imaging and Therapeutics in Alzheimer's Disease: Early Detection and Intervention 
    Videotaping for Future Webcast on Medscape Spotlight, Sponsored by Vindico Medical Education
    Boston MA - 1/14/2013
  • Clinical Conversations in Alzheimer's Disease 
    JHU CME for Webcast
    1/2/2013
  • Clinical Conversations in Alzheimer's Disease: Exploring the Diagnostic and Therapeutic Frontier 
    Webinar CME
    1/1/2013

Press Mentions

  • Dronabinol Safe, Effective for Alzheimer Disease with Agitation
    Dronabinol Safe, Effective for Alzheimer Disease with AgitationOctober 10th, 2024
  • Cannabis Product May Help Ease Agitation of Alzheimer’s
    Cannabis Product May Help Ease Agitation of Alzheimer’sOctober 9th, 2024
  • Clinical Trial Shows Synthetic Cannabis Reduces Agitation in Alzheimer’s Disease
    Clinical Trial Shows Synthetic Cannabis Reduces Agitation in Alzheimer’s DiseaseOctober 2nd, 2024
  • Join now to see all

Grant Support

  • Diads-3: An RCT Of Venlafaxine For Depression In ADNational Institute On Aging2011
  • The Role Of STIM1 In Cardiac And Skeletal Muscle FunctionNational Heart, Lung, And Blood Institute2009–2011
  • PET Imaging Of Activated Microglia In Alzheimer'S DiseaseNational Institute On Aging2008–2011
  • Apathy In Alzheimer'S Disease Methylphenidate TrialNational Institute On Aging2009–2010